Impact of hormone receptor (HR) status on clinicopathological features, patterns of recurrence, and clinical outcomes among patients (pts) with human epidermal growth factor receptor-2 positive (HER2) breast cancer (BC) in the National Comprehensive Cancer Network (NCCN).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Dana-Farber Cancer Institute, City Of Hope National Medical Center, City of Hope, Duke Medical Center, Massachusetts General Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, The Ohio State University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2597274344